Huizhi Heyuan is an innovative enterprise specializing in biological reagent solutions for subcellular enzymes, primary cells, and organoids. The company has developed subcellular enzymes such as liver lysosomes, liver microsomes/liver S9/induced liver S9/liver Cytosol, CYP/UGT recombinases, as well as primary cells such as liver cells/kidney cells/lung cells, primary PBMCs, SMCs, and cell separation, magnetic bead sorting, cell expansion kits, cell culture media, frozen storage solution products, primary liver cell sandwich models/3D spheroids, and primary liver cell organoids around primary cell related products, providing key tools for in vitro evaluation of innovative drug development and achieving high-end evaluation of primary cells and other organoids. Domestic substitution of biological reagents. The company has served over 2000 clients, including WuXi AppTec, Kanglong Huacheng, and Zhaoyan, Sanofi，MERCK，BMS， Renowned CROs and innovative pharmaceutical companies such as BeiGene and Hengrui Pharmaceutical.